KONINKLIJKE PHILIPS NV (PHI1.DE) Stock Fundamental Analysis
FRA:PHI1 • NL0000009538
27.13 EUR
+0.15 (+0.56%)
Last: Feb 27, 2026, 07:00 PM
We assign a fundamental rating of 2 out of 10 to PHI1. PHI1 was compared to 63 industry peers in the Health Care Equipment & Supplies industry. PHI1 has a bad profitability rating. Also its financial health evaluation is rather negative. PHI1 is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- PHI1 had positive earnings in the past year.
- In the past year PHI1 had a positive cash flow from operations.
- In multiple years PHI1 reported negative net income over the last 5 years.
- PHI1 had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- PHI1 has a Return On Assets of 3.32%. This is comparable to the rest of the industry: PHI1 outperforms 46.15% of its industry peers.
- PHI1 has a Return On Equity (8.17%) which is in line with its industry peers.
- PHI1 has a Return On Invested Capital (5.16%) which is in line with its industry peers.
- PHI1 had an Average Return On Invested Capital over the past 3 years of 3.24%. This is significantly below the industry average of 9.88%.
- The last Return On Invested Capital (5.16%) for PHI1 is above the 3 year average (3.24%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.32% | ||
| ROE | 8.17% | ||
| ROIC | 5.16% |
ROA(3y)-0.23%
ROA(5y)0.96%
ROE(3y)-0.52%
ROE(5y)1.86%
ROIC(3y)3.24%
ROIC(5y)N/A
1.3 Margins
- PHI1's Profit Margin of 5.02% is in line compared to the rest of the industry. PHI1 outperforms 46.15% of its industry peers.
- PHI1's Profit Margin has declined in the last couple of years.
- PHI1 has a Operating Margin of 7.98%. This is comparable to the rest of the industry: PHI1 outperforms 43.08% of its industry peers.
- PHI1's Operating Margin has declined in the last couple of years.
- Looking at the Gross Margin, with a value of 45.18%, PHI1 is doing worse than 73.85% of the companies in the same industry.
- PHI1's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.98% | ||
| PM (TTM) | 5.02% | ||
| GM | 45.18% |
OM growth 3YN/A
OM growth 5Y-5.59%
PM growth 3YN/A
PM growth 5Y-6.05%
GM growth 3Y3.66%
GM growth 5Y-0.43%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PHI1 is destroying value.
- The number of shares outstanding for PHI1 has been increased compared to 1 year ago.
- PHI1 has more shares outstanding than it did 5 years ago.
- PHI1 has a worse debt/assets ratio than last year.
2.2 Solvency
- The Debt to FCF ratio of PHI1 is 16.37, which is on the high side as it means it would take PHI1, 16.37 years of fcf income to pay off all of its debts.
- With a Debt to FCF ratio value of 16.37, PHI1 is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
- A Debt/Equity ratio of 0.63 indicates that PHI1 is somewhat dependend on debt financing.
- PHI1's Debt to Equity ratio of 0.63 is on the low side compared to the rest of the industry. PHI1 is outperformed by 70.77% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 16.37 | ||
| Altman-Z | N/A |
ROIC/WACC0.79
WACC6.52%
2.3 Liquidity
- PHI1 has a Current Ratio of 1.32. This is a normal value and indicates that PHI1 is financially healthy and should not expect problems in meeting its short term obligations.
- PHI1 has a worse Current ratio (1.32) than 61.54% of its industry peers.
- PHI1 has a Quick Ratio of 1.32. This is a bad value and indicates that PHI1 is not financially healthy enough and could expect problems in meeting its short term obligations.
- PHI1's Quick ratio of 0.94 is on the low side compared to the rest of the industry. PHI1 is outperformed by 66.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.32 | ||
| Quick Ratio | 0.94 |
3. Growth
3.1 Past
- The Earnings Per Share has been growing slightly by 6.11% over the past year.
- Measured over the past years, PHI1 shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.62% on average per year.
- Looking at the last year, PHI1 shows a decrease in Revenue. The Revenue has decreased by -1.04% in the last year.
- The Revenue has been growing slightly by 0.59% on average over the past years.
EPS 1Y (TTM)6.11%
EPS 3Y15.66%
EPS 5Y-6.62%
EPS Q2Q%-1.96%
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y0.01%
Revenue growth 5Y0.59%
Sales Q2Q%1.05%
3.2 Future
- The Earnings Per Share is expected to grow by 8.42% on average over the next years. This is quite good.
- Based on estimates for the next years, PHI1 will show a small growth in Revenue. The Revenue will grow by 3.77% on average per year.
EPS Next Y3.51%
EPS Next 2Y8.11%
EPS Next 3Y15.73%
EPS Next 5Y8.42%
Revenue Next Year1.71%
Revenue Next 2Y3.03%
Revenue Next 3Y3.53%
Revenue Next 5Y3.77%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- PHI1 is valuated rather expensively with a Price/Earnings ratio of 18.46.
- Based on the Price/Earnings ratio, PHI1 is valued a bit cheaper than the industry average as 78.46% of the companies are valued more expensively.
- PHI1 is valuated rather cheaply when we compare the Price/Earnings ratio to 27.07, which is the current average of the S&P500 Index.
- Based on the Price/Forward Earnings ratio of 17.83, the valuation of PHI1 can be described as rather expensive.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of PHI1 is on the same level as its industry peers.
- When comparing the Price/Forward Earnings ratio of PHI1 to the average of the S&P500 Index (28.05), we can say PHI1 is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.46 | ||
| Fwd PE | 17.83 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, PHI1 is valued a bit cheaper than 67.69% of the companies in the same industry.
- The rest of the industry has a similar Price/Free Cash Flow ratio as PHI1.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 52.88 | ||
| EV/EBITDA | 12.32 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- A more expensive valuation may be justified as PHI1's earnings are expected to grow with 15.73% in the coming years.
PEG (NY)5.25
PEG (5Y)N/A
EPS Next 2Y8.11%
EPS Next 3Y15.73%
5. Dividend
5.1 Amount
- PHI1 does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FRA:PHI1 (2/27/2026, 7:00:00 PM)
27.13
+0.15 (+0.56%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10 2026-02-10/bmo
Earnings (Next)05-06 2026-05-06
Inst Owners44.83%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap26.12B
Revenue(TTM)17.83B
Net Income(TTM)895.00M
Analysts73.33
Price Target29.29 (7.96%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0.35
Dividend Growth(5Y)216.55%
DP36.65%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.02%
Min EPS beat(2)3.95%
Max EPS beat(2)14.1%
EPS beat(4)4
Avg EPS beat(4)17.83%
Min EPS beat(4)3.95%
Max EPS beat(4)31.04%
EPS beat(8)4
Avg EPS beat(8)2.84%
EPS beat(12)6
Avg EPS beat(12)6.47%
EPS beat(16)7
Avg EPS beat(16)6.93%
Revenue beat(2)0
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-2.4%
Max Revenue beat(2)-0.86%
Revenue beat(4)0
Avg Revenue beat(4)-1.8%
Min Revenue beat(4)-2.4%
Max Revenue beat(4)-0.86%
Revenue beat(8)0
Avg Revenue beat(8)-2.61%
Revenue beat(12)1
Avg Revenue beat(12)-2.36%
Revenue beat(16)2
Avg Revenue beat(16)-1.72%
PT rev (1m)8.18%
PT rev (3m)5.91%
EPS NQ rev (1m)-20.3%
EPS NQ rev (3m)-14.31%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.56%
Revenue NQ rev (1m)2.87%
Revenue NQ rev (3m)2.28%
Revenue NY rev (1m)-0.99%
Revenue NY rev (3m)-1.57%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.46 | ||
| Fwd PE | 17.83 | ||
| P/S | 1.46 | ||
| P/FCF | 52.88 | ||
| P/OCF | 22.48 | ||
| P/B | 2.38 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.32 |
EPS(TTM)1.47
EY5.42%
EPS(NY)1.52
Fwd EY5.61%
FCF(TTM)0.51
FCFY1.89%
OCF(TTM)1.21
OCFY4.45%
SpS18.52
BVpS11.38
TBVpS-0.92
PEG (NY)5.25
PEG (5Y)N/A
Graham Number19.4
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.32% | ||
| ROE | 8.17% | ||
| ROCE | 7.33% | ||
| ROIC | 5.16% | ||
| ROICexc | 6.02% | ||
| ROICexgc | 20.88% | ||
| OM | 7.98% | ||
| PM (TTM) | 5.02% | ||
| GM | 45.18% | ||
| FCFM | 2.77% |
ROA(3y)-0.23%
ROA(5y)0.96%
ROE(3y)-0.52%
ROE(5y)1.86%
ROIC(3y)3.24%
ROIC(5y)N/A
ROICexc(3y)3.72%
ROICexc(5y)N/A
ROICexgc(3y)12.84%
ROICexgc(5y)N/A
ROCE(3y)4.62%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-1.31%
ROICexc growth 3YN/A
ROICexc growth 5Y-4.82%
OM growth 3YN/A
OM growth 5Y-5.59%
PM growth 3YN/A
PM growth 5Y-6.05%
GM growth 3Y3.66%
GM growth 5Y-0.43%
F-Score7
Asset Turnover0.66
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 16.37 | ||
| Debt/EBITDA | 2.72 | ||
| Cap/Depr | 59.38% | ||
| Cap/Sales | 3.75% | ||
| Interest Coverage | 5.63 | ||
| Cash Conversion | 45.59% | ||
| Profit Quality | 55.2% | ||
| Current Ratio | 1.32 | ||
| Quick Ratio | 0.94 | ||
| Altman-Z | N/A |
F-Score7
WACC6.52%
ROIC/WACC0.79
Cap/Depr(3y)53.03%
Cap/Depr(5y)53.41%
Cap/Sales(3y)3.68%
Cap/Sales(5y)4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.11%
EPS 3Y15.66%
EPS 5Y-6.62%
EPS Q2Q%-1.96%
EPS Next Y3.51%
EPS Next 2Y8.11%
EPS Next 3Y15.73%
EPS Next 5Y8.42%
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y0.01%
Revenue growth 5Y0.59%
Sales Q2Q%1.05%
Revenue Next Year1.71%
Revenue Next 2Y3.03%
Revenue Next 3Y3.53%
Revenue Next 5Y3.77%
EBIT growth 1Y15922.2%
EBIT growth 3YN/A
EBIT growth 5Y-5.03%
EBIT Next Year68.56%
EBIT Next 3Y26.52%
EBIT Next 5Y17.27%
FCF growth 1Y-43.86%
FCF growth 3YN/A
FCF growth 5Y-22.31%
OCF growth 1Y-25.32%
OCF growth 3YN/A
OCF growth 5Y-15.14%
KONINKLIJKE PHILIPS NV / PHI1.DE FAQ
What is the ChartMill fundamental rating of KONINKLIJKE PHILIPS NV (PHI1.DE) stock?
ChartMill assigns a fundamental rating of 2 / 10 to PHI1.DE.
What is the valuation status for PHI1 stock?
ChartMill assigns a valuation rating of 3 / 10 to KONINKLIJKE PHILIPS NV (PHI1.DE). This can be considered as Overvalued.
How profitable is KONINKLIJKE PHILIPS NV (PHI1.DE) stock?
KONINKLIJKE PHILIPS NV (PHI1.DE) has a profitability rating of 3 / 10.
How financially healthy is KONINKLIJKE PHILIPS NV?
The financial health rating of KONINKLIJKE PHILIPS NV (PHI1.DE) is 1 / 10.
Can you provide the dividend sustainability for PHI1 stock?
The dividend rating of KONINKLIJKE PHILIPS NV (PHI1.DE) is 0 / 10 and the dividend payout ratio is 36.65%.